Shanghai/China and Ingelheim/Germany, 12 March 2012 - Boehringer Ingelheim today announced the expansion of its Animal Health business in China. One of the major moves is the opening of the Asian Veterinary Research & Development (R&D) Center in Zhangjiang, Shanghai. Boehringer Ingelheim invests 12 million euros in the center which is the largest of its kind established by a multinational pharmaceutical company in China. With the investment, the company creates 70 new scientific workplaces.
Boehringer Ingelheim sets up its first Asian Veterinary Research & Development Center in Shanghai
The research based pharmaceutical company accelerates the expansion of its Animal Health business in China
Mar 11, 2012
Latest in Home
NHTSA Investigating Tesla Door Handles That Could Trap Passengers
September 16, 2025
Ford to Cut Up to 1,000 Jobs at German Plant as EV Demand Lags
September 16, 2025
It's 'Do or Die' for EV Maker Rivian
September 16, 2025